Tango Therapeutics (TNGX) Other Operating Expenses (2020 - 2025)
Tango Therapeutics (TNGX) recorded quarterly Other Operating Expenses of $106.6 million in Q4 2025, up 426.86% quarter-over-quarter from -$32.6 million in Q3 2025, and down 12.61% on a YoY basis from $122.0 million in Q4 2024.
Tango Therapeutics (TNGX) Other Operating Expenses (2020 - 2025) Analysis & Trends
Tango Therapeutics' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $106.6 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tango Therapeutics | 4.05 Bn | 3.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 106.64 Mn |
| Sep 30, 2025 | -32.63 Mn |
| Mar 31, 2025 | -39.10 Mn |
| Dec 31, 2024 | 122.03 Mn |
| Sep 30, 2024 | -36.97 Mn |
| Dec 31, 2020 | 2.91 Mn |